You are here

  • Home
  • Archive
  • Volume 90, Issue 12
  • 141 Switching from double-blind entacapone or placebo to open-label opicapone: NMSS results (1-year extension BIPARK-I study)

Article metrics

Article menu
Download PDFPDF
Parallel session 6: Clinical Neurology 2
141 Switching from double-blind entacapone or placebo to open-label opicapone: NMSS results (1-year extension BIPARK-I study)

 

Online download statistics by month:

Online download statistics by month: November 2019 to October 2024

AbstractFullPdf
Nov 201917005
Dec 20197600
Jan 20204203
Feb 20202201
Mar 20201501
Apr 20202000
May 20202600
Jun 20201200
Jul 20201401
Aug 20201200
Sep 20202800
Oct 20205400
Nov 20201200
Dec 20203000
Jan 20212701
Feb 20211800
Mar 20211600
Apr 20211000
May 2021500
Aug 2021101
Sep 2021201
Oct 2021100
Nov 2021801
Dec 2021800
Jan 20222000
Feb 20223000
Mar 20221201
Apr 20221400
May 20223500
Jun 20223800
Jul 20221200
Aug 20222500
Sep 20222800
Oct 20222700
Nov 20221600
Dec 20222600
Jan 20231200
Feb 20236600
Mar 20233201
Apr 20232601
May 20231501
Jun 2023800
Jul 20231400
Aug 2023700
Sep 2023400
Oct 20231301
Nov 20233200
Dec 20231201
Jan 2024600
Feb 2024200
Mar 20242400
Apr 20242800
May 20242000
Jun 20242500
Jul 20245200
Aug 20241700
Sep 20246200
Oct 20241402
Total1403023